document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center confidential style font size margin margin bottom nbsp style line height margin margin bottom border bottom solid nbsp style line height margin margin bottom border bottom solid nbsp style margin margin bottom font size font family time roman align center research license agreement style margin margin bottom font size font family time roman align center between style margin margin bottom font size font family time roman align center janssen biotech style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center aduro biotech style margin margin bottom font size font family time roman align center executed october nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom text indent font size font family time roman this research license agreement this agreement made october execution date between aduro biotech delaware corporation having principal place business bancroft berkeley hereinafter aduro janssen biotech pennsylvania corporation having place business ridgeview drive horsham hereinafter aduro referred individually herein party together party style margin margin bottom font size font family time roman align center witnesseth style margin margin bottom text indent font size font family time roman whereas aduro posse expertise resource related research discovery therapeutic cancer immunotherapeutics based inter alia attenuated strain listeria monocytogenes style margin margin bottom text indent font size font family time roman whereas posse expertise resource relating discovery development manufacture marketing sale ethical pharmaceutical product therapeutic prophylactic diagnostic human animal style margin margin bottom text indent font size font family time roman whereas wish obtain aduro willing grant worldwide exclusive license aduro right intellectual property exploit defined below licensed immunotherapeutics defined below term subject condition forth herein style margin margin bottom text indent font size font family time roman therefore consideration premise mutual covenant herein contained aduro have agreed follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign definition table style margin margin bottom text indent font size font family time roman used this agreement following term shall have following meaning each case unless context clearly requires otherwise singular shall include plural vice versa style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign immunotherapeutic mean listeria strain engineered express avoidance doubt immunotherapeutic includes modification thereto table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign agreement mean that certain research license agreement dated nbsp between aduro directed immunotherapeutics defined therein table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign achieved milestone shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign action shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign active development mean that given time party affiliate sublicensees directly through third party contractor more following development activity formulation development study protocol design activity awaiting protocol approval from applicable institutional review board patient recruitment patient treatment data analysis report writing clinical trial regulatory file being drafted pending pricing marketing approval pending manufacturing investment work synthetic process development drug synthesis packaging development manufacturing scale validation preclinical vitro characterization decision awaited from formal research development committee party affiliate sublicensees initiate preceding activity table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign aduro shall have meaning ascribed thereto preamble table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign aduro core patent mean aduro patent other than those that licensed immunotherapeutic specific patent table style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign aduro core technology mean aduro intellectual property that specifically directed aduro listeria platform technology including aduro core patent aduro core technology excludes nbsp licensed immunotherapeutic specific patent nbsp aduro know referencing licensed immunotherapeutics generally applicable aduro listeria platform table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign aduro immunotherapeutic shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign aduro immunotherapeutic antigen shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign aduro intellectual property mean nbsp aduro know nbsp aduro patent nbsp other intellectual property controlled aduro that relates licensed immunotherapeutic material table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign aduro know mean information that during term nbsp controlled aduro affiliate nbsp useful reasonably necessary exploitation licensed immunotherapeutic including copyright right data database droit moral associated with foregoing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign aduro patent mean patent that during term nbsp controlled aduro affiliate nbsp useful reasonably necessary exploitation licensed immunotherapeutic list patent known aduro patent existing execution date appended hereto aduro patent schedule shall updated aduro annually otherwise upon reasonable request reflect appropriate addition revision thereto during course this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign aduro project shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign affiliate with respect party corporation other business entity that directly indirectly control controlled under common control with such party purpose this definition term control including with correlative meaning term controlled under common control with used with respect party shall mean possession least voting stock other ownership interest other corporation entity power direct cause direction management policy corporation other entity power elect appoint least member governing body corporation other entity through ownership outstanding voting security contract otherwise affiliate entity affiliated with specified entity mean entity that directly indirectly control controlled under common control with entity specified notwithstanding foregoing purpose clarity none morningside venture investment limited gerald chan stephanie brien shall deemed affiliate aduro table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign agreement shall have meaning ascribed thereto preamble table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign antigen mean substance intended evoke active immune response table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign antigen change mean addition substitution removal antigen from existing antigen that part lead immunotherapeutic other immunotherapeutic previously created permitted derivative immunotherapeutic clarity addition subtraction substitution antigen licensed immunotherapeutic antigen change modification table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign antigen exception shall have meaning ascribed thereto section nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign antigen variation mean modification antigen whereby modified antigen variant such antigen table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign applicable mean applicable statute rule regulation ordinance other pronouncement having binding effect applicable government authority court tribunal agency legislative body commission other instrumentality nbsp government country nbsp state province county city other political subdivision thereof nbsp supranational body table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign available antigen mean antigen antigen proposed inclusion permitted derivative immunotherapeutic forth permitted derivative notice determined available pursuant section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign antigen mean antigen with sequence attached hereto antigen schedule variant thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign base strain mean listeria strain described submission manufacturing update plan such base strain modified aduro pursuant section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign base strain modification mean base strain clarity neither nbsp licensed immunotherapeutic part developing immunotherapeutic permitted derivative immunotherapeutic nbsp development implementation nbsp development implementation constitute base strain modification table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign mean biological license application filed pursuant including document data other information concerning licensed immunotherapeutic that necessary included approval market licensed immunotherapeutic supplement amendment including supplemental biological license application that filed with respect foregoing more fully defined equivalent application filed with equivalent regulatory authority jurisdiction territory other than united state table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign bpcia shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign bundled product shall have meaning ascribed thereto definition sale table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign calendar month mean calendar month based universal calendar table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign calendar quarter mean calendar quarter based universal calendar table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign calendar year mean period twelve nbsp consecutive month based universal calendar that year table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign cancer type mean each nbsp nbsp nbsp would purpose this agreement respectively considered nbsp avoidance doubt cancer type example table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign claim shall have meaning ascribed thereto section nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign closing date shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign collaboration term mean period starting closing date expiring date that aduro completed activity under submission manufacturing update plan table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign combination product shall have meaning ascribed thereto definition sale table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign commencement expansion cohort mean table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign commercialize commercialization mean activity directed marketing promoting manufacturing packaging distributing offering sale selling product service importing product sale table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign commercially reasonable effort mean party level effort normally used pharmaceutical biotechnology company applicable comparable size resource such party consistent with effort such party would commonly devote with exercise prudent scientific business judgment relating research development commercialization biotechnology product with similar product characteristic that similar market potential similar stage development product life resulting from research effort that party otherwise acquired exclusively licensed with right sublicense taking into account issue patent coverage safety efficacy product profile competitiveness marketplace intellectual property position regulatory structure likelihood approval anticipated profitability including cost good pricing reimbursement status achieved anticipated alternative product product candidate other factor table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign compulsory license mean patent license that granted ordered granted government country individual entity perform have performed activity development commercialization pharmaceutical product that covered claim patent that country with ultimate purpose enabling entity market sell such product benefit public health public policy reason table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign control controlled mean possession party legal right power authority whether ownership license otherwise grant license sublicense intellectual property right otherwise disclose proprietary trade secret information such other party without violating term agreement with third party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign controlling party shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign cover covering covered mean with respect licensed immunotherapeutic with respect practice technology that absence license granted under valid claim given patent manufacture offer sale sale importation such licensed immunotherapeutic practice such technology would infringe such valid claim table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign shall have meaning ascribed thereto definition rate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign accelerated rule shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign rule shall have meaning ascribed thereto section nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign currency hedge rate calculated weighted average hedge rate outstanding external foreign currency forward hedge contract johnson nbsp johnson global treasury service center gtsc affiliate with third party bank hedge contract entered into protect transactional foreign exchange risk exposure reducing impact foreign currency volatility through systematic build yearly currency hedge rate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign data exclusivity right mean right protection granted regulatory authority jurisdiction providing with respect drug product nbsp marketing exclusivity that prevents regulatory authority from accepting approving application regulatory approval such drug application whether abbreviated application relating biosimilar product submitted party pharmaceutical product including generic biosimilar similar medicinal product generic competing version pharmaceutical product that same bioequivalent drug product such through molecular entity biological product orphan drug pediatric exclusivity designation applicable regulatory authority exclusive right sell pursuant data exclusivity provision such those under directive regulation nbsp data protection regulatory data relating drug product against unfair commercial public release consistent with stringent than article trip agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign development including variation such develop developing mean preclinical clinical drug development activity including among other thing test method development stability testing toxicology formulation process development manufacturing scale development stage manufacturing quality assurance quality control development statistical analysis report writing clinical study regulatory affair product approval registration purpose this agreement development shall include without limitation phase phase phase post phase clinical trial table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign disclosing party shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign disclosure shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign dispute shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign shall mean antigen with sequence attached hereto antigen schedule variant thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign shall mean antigen with sequence attached hereto antigen schedule variant thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign mean european medicine agency successor agency thereto table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign major market mean france germany italy spain united kingdom table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign execution date shall have meaning ascribed thereto preamble table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign exploitation including variation such exploit mean research development manufacture having manufactured having used sale offer sale importation other exploitation product service table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign mean united state food drug administration successor agency thereto table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign field mean table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign first commercial sale mean with respect licensed immunotherapeutic first sale length transaction such licensed immunotherapeutic third party affiliate sublicensee country following licensed immunotherapeutic provided nbsp nbsp nbsp nbsp shall constitute first commercial sale addition shall constitute first commercial sale table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign force majeure shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign mean full time equivalent person year consisting total hour year scientific technical regulatory professional work undertaken aduro affiliate employee including standard time pursuant aduro affiliate company policy vacation holiday sick time like table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign cost mean period product nbsp actual total ftes used aduro perform development manufacturing activity pursuant development work under section nbsp other development technology transfer plan during such period nbsp rate avoidance doubt individual record more than given calendar year rated amount portion thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign rate mean rate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign gmps shall mean good manufacturing practice under amended from time time table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign gtsc shall have meaning ascribed thereto definition currency hedge rate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign waiting period shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign mean investigational drug application more fully defined amended from time time that filed with equivalent filing made with regulatory authority another country territory other than united state purpose this part synonymous with notice claim investigational exemption drug table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign approval mean expiration thirty waiting period effectiveness earlier approval proceed with clinical trial under clinical hold imposed notification from division director that clinical trial proceed table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign submission manufacturing update plan mean activity specified submission manufacturing update plan schedule attached hereto modified accordance with section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnification claim shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnified party shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnifying party shall have meaning ascribed thereto section nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign information mean information generally known public including screen model invention practice method knowledge know skill experience test data including pharmacological toxicological clinical test data analytical quality control data marketing pricing distribution cost sale manufacturing data manufacturing secret procedure secret process report plan design prototype test result working drawing method including testing method formula recipe material performance specification current accumulated experience acquired result technical research otherwise patent legal data related chemical biological other tangible material table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign initiation phase trial mean first dosing patient phase clinical trial table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign initiation phase trial mean first dosing patient phase clinical trial table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign investigator initiated study mean study performed third party investigator sponsor study table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign shall have meaning ascribed thereto preamble table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign core improvement patent shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign improvement aduro core technology shall mean enhancement improvement modification aduro core technology that developed conceived reduced practice behalf affiliate their sublicensees subcontractor connection with exploitation licensed immunotherapeutic whether under this agreement defined agreement clarity improvement aduro core technology includes core improvement patent information related improvement aduro core technology table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign know mean information that nbsp under control affiliate during term nbsp useful reasonably necessary exploitation licensed immunotherapeutic including copyright right data database droit moral associated with foregoing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign patent mean patent that nbsp controlled affiliate during term nbsp useful reasonably necessary exploitation licensed immunotherapeutic table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign permitted derivative immunotherapeutic shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign project shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign universal calendar mean calendar attached hereto calendar year schedule shall updated each subsequent calendar year consistent with that used internal business purpose table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign joint project shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign joint steering committee mean committee established pursuant section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign lead immunotherapeutic mean immunotherapeutic table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign licensed immunotherapeutics mean immunotherapeutics permitted derivative immunotherapeutics table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign licensed immunotherapeutic material mean master cell bank such other tangible item useful reasonably necessary development manufacturing licensed immunotherapeutics including those forth technology transfer plan schedule table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign licensed immunotherapeutic specific patent mean aduro patent claim which contain sake clarity licensed immunotherapeutic specific patent include aduro patent claim which aduro patent that contain claim that contain would included licensed immunotherapeutic specific patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign loss shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign manufacturing including variation such manufacture mean performance activity directed producing manufacturing processing filling finishing packaging labelling quality control quality assurance testing release shipping storage licensed immunotherapeutics including licensed immunotherapeutic development manufacturing clinical supply excluding commercialization development activity table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign master cell bank mean master cell bank described submission manufacturing update plan schedule lead immunotherapeutic other master cell bank prepared aduro connection with other licensed immunotherapeutic table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign antigen shall mean antigen with sequence attached hereto antigen schedule variant thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign modification including variant such modify modified mean adaptation enhancement redesign other change product process table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign sale mean gross amount sale licensed immunotherapeutic affiliate sublicensees third party purchaser length transaction following deduction gross sale price with respect such sale table style margin margin bottom margin left text indent font size font family time roman normal customary trade cash quantity discount allowance deduction credit form deduction actually allowed with respect sale such licensed immunotherapeutic extent already reflected amount invoiced excluding commission commercialization style margin margin bottom margin left text indent font size font family time roman excise tariff sale custom duty other government charge imposed sale such licensed immunotherapeutic extent separately itemized invoice specifically excluding clarity income assessed against income arising from such sale style margin margin bottom margin left text indent font size font family time roman outbound freight shipment insurance cost extent separately itemized invoice style margin margin bottom margin left text indent font size font family time roman compulsory payment cash rebate related sale such licensed immunotherapeutics paid governmental authority agent thereof pursuant governmental regulation including government levied result healthcare reform policy style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom margin left text indent font size font family time roman retroactive price reduction credit allowance rejection return such licensed immunotherapeutic including recall damaged good billing error style margin margin bottom margin left text indent font size font family time roman rebate chargebacks discount equivalent thereof managed health care organization pharmacy benefit manager equivalent thereof federal state provincial local other government their agency purchaser reimbursers trade customer style margin margin bottom margin left text indent font size font family time roman amount equal percent such gross amount cover item forth above style margin margin bottom margin left font size font family time roman foregoing deduction shall such discount allowance credit rebate other deduction shall sale licensed immunotherapeutic between affiliate sublicensees sale third party shall excluded from sale calculation purpose provided that resale purchaser third party distributor third party shall included sale shall excluded from sale calculation purpose style margin margin bottom margin left font size font family time roman event licensed immunotherapeutic sold combination with other product affiliate sublicensees third party customer receives discount such bundling product clarity this situation describes bundling more separate product each finished dosage form fixed combination more active ingredient single finished product bundled product sale such licensed immunotherapeutic purpose determining royalty sale based milestone payment shall determined event that then purpose determining royalty payment respect such licensed immunotherapeutic style margin margin bottom margin left font size font family time roman licensed immunotherapeutic sold form fixed combination single finished product containing both such licensed immunotherapeutic more other active ingredient separate molecular entity that licensed immunotherapeutics combination product sale such licensed immunotherapeutic purpose calculating royalty sale based milestone payment owed under this agreement sale such licensed immunotherapeutic shall determined follows first sale shall calculated neither such licensed immunotherapeutic other active ingredient combination product sold separately style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign antigen mean antigen with sequence attached hereto antigen schedule variant thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign other development shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign pocket expense mean expense actually paid with mark third party that either nbsp affiliate party claiming such expense nbsp affiliate that party where such payment limited reimbursing such affiliate expense actually paid such affiliate third party that affiliate party claiming such expense table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign overlapping product shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign party party shall have meaning ascribed thereto preamble table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign patent mean patent patent application including continuation continuation part division provisionals substitute application claiming priority such patent patent application patent issued with respect such patent application reissue examination renewal extension including supplemental patent certificate such patent confirmation patent registration patent patent addition based such patent foreign counterpart foregoing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indication shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign antigen mean antigen with sequence attached hereto antigen schedule variant thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign permitted derivative notice shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign permitted derivative immunotherapeutic mean listeria strain permitted developed under term section nbsp avoidance doubt permitted derivative immunotherapeutics includes modification thereto table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign phase clinical trial mean study human obtain initial data regarding safety tolerability pharmacological activity pharmacokinetics research development candidate alone combination with another active agent more fully defined table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign phase clinical trial mean human clinical trial conducted inclusion that portion submission approval process that provides trial limited number patient purpose collecting data dosage evaluating side effect safety collecting preliminary information regarding efficacy proposed therapeutic indication more fully defined amended from time time equivalent submission with similar requirement other country territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign phase clinical trial mean study human efficacy safety research development candidate alone combination with another active agent that prospectively designed demonstrate statistically whether research development candidate alone combination with another active agent safe effective particular indication more fully defined amended from time time equivalent submission with similar requirement other country territory manner intended sufficient obtain regulatory approval market that research development candidate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign planned shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign platform update shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign platform early update period shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign price reimbursement approval mean approval license registration authorization supranational national regional state local regulatory authority other regulatory agency department bureau governmental entity necessary determine pricing licensed immunotherapeutic reimbursement level relevant health authority provider other funding institution supranational national regional state local level table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign process modification mean change related exploitation licensed immunotherapeutic that intended enhance ability effectively exploit licensed immunotherapeutic that constitute either base strain modification antigen change example process modification would include modification that improve licensed immunotherapeutic stability delivery packaging storage shelf life dosage other similar matter table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign protocol shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign receiving party shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign regulatory approval mean approval license registration authorization excluding price reimbursement approval regulatory authority country supra national organization such that required marketing sale licensed immunotherapeutic such country conduct clinical study such country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign regulatory authority mean regulatory agency ministry department other governmental body having authority country control development manufacture marketing sale pharmaceutical biologic product including table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign remediation plan mean plan attached remediation schedule agreement describing change made manufacturing same amended pursuant this agreement agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign antigen mean antigen with sequence attached hereto antigen schedule variant thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign royalty term shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign skipped milestone shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign sublicensee mean with respect particular licensed immunotherapeutic third party whom granted license sublicense under aduro patent aduro know make sell such licensed immunotherapeutic extent permitted under section nbsp hereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign technology transfer completion plan shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign technology transfer plan shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign term shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign territory mean entire world table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign third party mean individual corporation other entity other than aduro affiliate either party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign third party antigen shall have meaning ascribed thereto section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign third party license mean license taken affiliate sublicensees from third party wherein licensed intellectual property thereof cover development manufacturing commercialization licensed immunotherapeutic table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign agreement mean exclusive license between effective amended accordance with term table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign valid claim mean claim aduro patent which claim expired been held invalid appealed unappealable decision court other appropriate body competent jurisdiction purpose royalty determination payment table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign variant mean with respect protein peptide nbsp other protein peptide identical sequence such protein peptide regardless post translational modification including modification glycosylation fucosylation phosphorization methylation nbsp other protein peptide translated from mrna splice variant transcribed from same human gene that encodes such protein peptide nbsp protein peptide having least homology such protein peptide nbsp truncated form including fragment thereof foregoing that intended elicit immune response such protein peptide table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign license grant table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign license table style margin margin bottom text indent font size font family time roman license licensed immunotherapeutics subject term condition this agreement including section nbsp aduro hereby grant exclusive license even aduro under aduro intellectual property that owned aduro affiliate solely exploit licensed immunotherapeutics field including nbsp combination with other product service with respect permitted derivative immunotherapeutics nbsp combination with other product service with respect immunotherapeutics with right sublicense permitted section nbsp style margin margin bottom text indent font size font family time roman sublicense licensed immunotherapeutics style margin margin bottom margin left text indent font size font family time roman addition subject term condition this agreement aduro hereby grant exclusive sublicense even aduro under aduro intellectual property that controlled owned aduro affiliate closing date including aduro intellectual property controlled aduro pursuant agreement solely exploit licensed immunotherapeutics field including nbsp combination with other product service with respect permitted derivative immunotherapeutics nbsp combination with other product service with respect immunotherapeutics with right sublicense permitted section nbsp style margin margin bottom margin left text indent font size font family time roman addition subject term condition this agreement aduro hereby grant exclusive sublicense even aduro under aduro intellectual property that becomes controlled aduro subsequent closing date solely exploit licensed immunotherapeutics field including nbsp combination with other product service with respect permitted derivative immunotherapeutics nbsp combination with other product service with respect immunotherapeutics with right sublicense permitted section nbsp material additional payment would required aduro sublicense same aduro shall give prompt written notice such aduro intellectual property style margin margin bottom margin left text indent font size font family time roman with respect aduro intellectual property that owned aduro becomes controlled aduro subsequent execution date material additional payment including royalty would required aduro sublicense same then aduro hereby grant exclusive sublicense even aduro under such aduro intellectual property solely exploit licensed immunotherapeutics field including nbsp combination with other product service with respect permitted derivative immunotherapeutics nbsp combination with other product service with respect immunotherapeutics with right sublicense permitted section nbsp provided that agrees writing reimburse such amount aduro such amount directly aduro shall promptly notify such necessary payment amount thereof party shall then style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman improvement aduro core technology style margin margin bottom margin left text indent font size font family time roman agrees that will reasonable effort ensure owns control improvement aduro core technology style margin margin bottom margin left text indent font size font family time roman hereby grant aduro exclusive with only license including right grant sublicenses nbsp improvement aduro core technology nbsp enhancement improvement modification aduro core technology each case controlled affiliate solely exploit style margin margin bottom margin left text indent font size font family time roman agrees that affiliate will grant third party right improvement aduro core technology agree enforce aduro core technology against third party other than connection with exploitation licensed immunotherapeutic under this agreement licensed immunotherapeutic defined agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign sublicensing sublicense right licensed immunotherapeutics affiliate without aduro approval addition sublicense right more licensed immunotherapeutics more third party without aduro approval shall effort provide aduro than prior written notice such sublicense shall promptly respond good faith reasonable inquiry aduro with respect thereto such third party sublicensee must reasonably capable exploiting market opportunity territory licensed immunotherapeutic based likely development planned licensed immunotherapeutic time sublicense must agree writing assume obligation with respect licensed immunotherapeutic hereunder addition notwithstanding foregoing without need approval aduro distribute licensed immunotherapeutics through more third party granting necessary permissible license sublicenses such third party distributor such license sublicenses shall contain term consistent material respect with this agreement including without limitation section hereof shall responsible performance sublicensees failure sublicensees comply with applicable term condition this agreement sublicensees shall table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign performance affiliate party agree that affiliate either party perform that party obligation under this agreement behalf that party provided that party shall fully responsible liable action such affiliate performance such obligation shall ensure that such affiliate comply with term this agreement nothing this section nbsp shall relieve either party obligation under provision this agreement extent that such obligation satisfied performance thereof such affiliate that party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign retained right subject section nbsp notwithstanding anything that construed contrary herein aduro retains right aduro intellectual property order exploit product other than licensed immunotherapeutics with other party throughout world avoidance doubt without prejudice right granted herein exploit licensed immunotherapeutics field including nbsp combination with other product service with respect permitted derivative immunotherapeutics nbsp combination with other product service with respect immunotherapeutics license granted this agreement sell aduro product aduro product platform technology including small molecule biomarker diagnostic like other than licensed immunotherapeutics whether alone combination with licensed immunotherapeutics regardless whether licensed immunotherapeutics sold under labelling combination with aduro product aduro product platform technology table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign development work table style margin margin bottom text indent font size font family time roman process modification make process modification immunotherapeutic permitted derivative immunotherapeutic independently aduro without aduro consent process modification developed independently aduro shall constitute aduro intellectual property will disclosed aduro style margin margin bottom text indent font size font family time roman base strain modification antigen variation style margin margin bottom margin left text indent font size font family time roman aduro upon request aduro shall base strain modification antigen variation desire aduro assistance with respect base strain modification antigen variation shall request same writing such base strain modification antigen variation requested such aduro shall shall described section nbsp clarity base strain modification antigen variation shall style margin margin bottom margin left text indent font size font family time roman aduro base strain modification antigen variation developed independently aduro constitute aduro intellectual property licensed hereunder will disclosed aduro style margin margin bottom margin left text indent font size font family time roman completed modification immunotherapeutic permitted derivative immunotherapeutics modified pursuant this section nbsp shall thereafter immunotherapeutic permitted derivative immunotherapeutic case purpose this agreement style margin margin bottom text indent font size font family time roman permitted derivative immunotherapeutics style margin margin bottom margin left text indent font size font family time roman available antigen mean style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign antigen table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign antigen that subject agreement with respect thereto given which agreement would permit third party antigen that aduro immunotherapeutic antigen unless fall within antigen exception table style margin margin bottom margin left text indent font size font family time roman aduro immunotherapeutic antigen mean antigen aduro immunotherapeutic provided that antigen from aduro immunotherapeutic proposed permitted derivative immunotherapeutic long antigen chosen antigen exception purpose forgoing calculation antigen copy same antigen variant antigen part aduro immunotherapeutic shall deemed single antigen following chart illustrative purpose style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign align center valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign table style margin margin bottom font size font family time roman style margin margin bottom margin left text indent font size font family time roman should wish develop permitted derivative immunotherapeutic then shall send aduro written notice same each permitted derivative notice aduro shall antigen permitted derivative notice then notwithstanding anything that construed contrary agrees that licensed immunotherapeutic shall contain antigen even addition antigen deemed variant hereunder absent prior written consent aduro which consent shall unreasonably withheld avoidance doubt foregoing limitation apply antigen style margin margin bottom margin left text indent font size font family time roman following such consultation relevant antigen available antigen desire antigen change that meet requirement herein shall request same writing such aduro shall perform activity specified such plan shall reimburse aduro specified section nbsp shall permitted during term after closing date style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman with respect permitted derivative immunotherapeutic developed pursuant this section nbsp agrees that except agreed writing otherwise aduro shall such permitted derivative immunotherapeutic other than provided that choose more permitted derivative therapeutic that nbsp nbsp each such permitted derivative immunotherapeutic permitted derivative immunotherapeutic development commercialization indication provided that another example then conversely then would style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman avoidance doubt foregoing limitation shall also preclude furthermore affiliate shall except agreed writing aduro notwithstanding foregoing nothing this agreement shall prevent restrict nbsp from manner that deems nbsp shall have obligation pursuant this section nbsp style margin margin bottom text indent font size font family time roman pocket expense cost pocket expense cost incurred calendar quarter basis accordance with specified activity forth plan agreed party pursuant section shall reimbursed aduro total budget corresponding specified activity such calendar quarter provided that cost activity outsourced third party shall indicated estimate range unit hour cost case applicable plan budget treated accordingly within calendar each calendar month aduro shall submit invoice accordance with invoice procedure forth invoice procedure schedule cost pocket expense incurred during such calendar month together with written report setting forth reasonable detail such cost expense reimbursement shall made within after receipt valid invoice forth invoice procedure schedule style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign exclusivity table style margin margin bottom text indent font size font family time roman during term except agreed writing otherwise aduro affiliate their respective sublicensees shall avoidance doubt foregoing limitation shall also performed third party including provision insofar been provided prior execution date furthermore aduro except agreed writing notwithstanding foregoing nothing this agreement shall prevent restrict aduro from nbsp manner that deems aduro shall style margin margin bottom text indent font size font family time roman during term aduro affiliate their respective sublicensees shall also grant third party right license aduro intellectual property exploit subject term this agreement which expressly provide otherwise aduro shall style margin margin bottom text indent font size font family time roman affiliate their respective sublicensees shall together unless approved writing aduro furthermore shall except agreed writing aduro notwithstanding foregoing nothing this agreement shall prevent restrict from nbsp manner that nbsp avoidance doubt foregoing limitation shall also style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman during term aduro affiliate their respective sublicensees shall develop manufacture commercialize their account behalf collaboration with third party listeria based immunotherapeutic that overlapping product clarity aduro right nbsp antigen other product including listeria based product nbsp antigen other product including listeria based product both party understand acknowledge that other party have present future initiative opportunity including initiative opportunity with third party involving similar product program technology process other than overlapping product that compete with product program technology process covered this agreement each party acknowledges agrees that nothing this agreement will construed representation warranty covenant inference that other party affiliate will itself develop manufacture market enter into business relationship with more third party develop manufacture market product program technology process other than overlapping product that covered this agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign submission manufacturing update plan table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign submission manufacturing update plan submission manufacturing update plan attached hereto submission manufacturing update plan schedule party shall each perform activity specified allocated submission manufacturing update plan time frame forth therein table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign other development agreed writing party should aduro agree perform together development manufacturing licensed immunotherapeutics other than forth submission manufacturing update plan each other development then such other development along with relevant timeline budget term condition particular such other development shall forth plan such other development that agreed executed party nbsp cost such other development shall aduro cost pocket expense unless otherwise agreed party reimbursed described section nbsp above table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign subcontracting each party perform activity support activity under this agreement through subcontracting third party contractor contract service organization provided that nbsp none right other party hereunder materially adversely affected result such subcontracting nbsp such third party subcontractor shall enter into appropriate written agreement obligating such third party bound obligation confidentiality restriction that restrictive than forth herein nbsp such party will obligate such third party agree writing assign license with right grant sublicenses such party invention patent covering such invention invented otherwise discovered generated such third party know generated such third party performing such service such party that necessary such party meet ownership license obligation under this agreement nbsp such party shall responsible appropriately monitoring directing managing supervising such subcontractor fails shall responsible omission such subcontractor notwithstanding foregoing except expressly forth otherwise submission manufacturing update plan aduro shall contract activity forth therein third party without prior written consent which consent shall unreasonably withheld delayed conditional table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign limitation development manufacturing obligation this article together with section development manufacturing obligation aduro under this agreement additional activity requested shall subject written agreement aduro sole discretion table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign oversight submission manufacturing update plan table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign general aduro shall conduct activity performed under submission manufacturing update plan cooperation with excluding activity conducted expressly forth therein table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign submission manufacturing update plan technology transfer plan manager promptly following closing date each party shall nominate manager respective point contact that party each submission manufacturing update plan technology transfer plan with respect development manufacturing regulatory other collaborative activity hereunder which manager will coordinate each party respective task ensure that query comment directed within organisation appropriately ensure efficient communication cooperation between party either party replace manager time upon written notice other party manager would expected attend meeting either party request table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign joint steering committee promptly after closing date party shall establish committee joint steering committee more fully described below shall review oversee activity performed under submission manufacturing update plan technology transfer plan provided however that shall have authority amend this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign membership meeting table style margin margin bottom text indent font size font family time roman shall comprise equal number representative from each aduro exact number such representative shall nbsp each party such other number party agree each party shall provide other with list initial member within after closing date notwithstanding that each party shall reasonable endeavour maintain continuity representation each party replace representative appoint proxy time giving prior written notification other each party reasonable discretion invite nbsp other employee such party attend meeting additional attendee shall subject prior consent other party each party will provide advance notice additional attendee will include without limitation meeting each party shall designate nbsp member chair style margin margin bottom text indent font size font family time roman until such time submission manufacturing update plan been completed shall meet least four nbsp time year manner time place party shall agree meeting that held person shall alternate between office party such other place party agree each party will responsible member expense incurred attending meeting style margin margin bottom text indent font size font family time roman chairperson shall responsible calling each meeting setting distributing agenda item advance meeting issuing appropriate minute each meeting within date such meeting shall allocate such responsibility between themselves minute shall considered accepted within from receipt objected traceable form chairperson style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign responsibility shall oversee conduct submission manufacturing update plan technology transfer plan that shall responsible without limitation following table style margin margin bottom text indent font size font family time roman review progress approval modification submission manufacturing update plan technology transfer plan including modification associated budget subject penultimate sentence this section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman formation committee development regulatory manufacturing otherwise appropriate which committee shall report their progress each regularly scheduled meeting with dispute among committee member referred resolution style margin margin bottom text indent font size font family time roman other responsibility assigned pursuant this agreement mutually agreed upon party writing from time time style margin margin bottom margin left font size font family time roman where decision would alter increase aduro contractual obligation financial obligation under this agreement including submission manufacturing update plan then role shall limited making recommendation party proposed decision such decision shall take effect unless until agreed party writing amendment this agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign quorum decision making meeting shall considered have quorum provided that chairperson from each party attendance majority present such meeting event member unable agree particular decision issue question shall referred management aduro designated article further deliberation event that aduro reach consensus matter within purview then except forth section nbsp above shall have final decision decision required permitted taken taken accordance with above without meeting taking place consent writing including electronic mail setting forth decision taken approved chairperson table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign termination following completion activity specified each submission manufacturing update plan technology transfer plan either party shall have right terminate written notice other table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign technology transfer master cell bank manufacturing platform update table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign initial technology transfer aduro will transfer arrange have transferred accordance with plan forth technology transfer plan schedule technology transfer plan nbsp copy aduro know useful reasonably necessary development manufacturing licensed immunotherapeutics nbsp material useful reasonably necessary development manufacturing licensed immunotherapeutics quantity submission manufacturing update plan forth therein reasonable quantity mutually agreed upon nbsp copy preclinical clinical analytical other assay useful reasonably necessary development manufacturing licensed immunotherapeutics orderly fashion including those specifically forth technology transfer schedule nbsp other item forth therein aduro shall commercially reasonable best effort complete such transfer within following closing date table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign technology transfer completion plan with respect aduro know material already transferred pursuant section nbsp above prior first meeting shall develop procedure make such plan technology transfer completion plan deems necessary such aduro know already exists electronic form then shall transferred electronic rather than paper form table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign transfer additional aduro know either aduro discovers aduro know material that have been transferred pursuant section above that useful reasonably necessary development commercialization licensed immunotherapeutic including which arises pursuant activity conducted under submission manufacturing update plan then aduro shall promptly transfer such material copy such aduro know such aduro know already exists electronic form then shall transferred electronic rather than paper form table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign master cell bank manufacturing pursuant submission manufacturing update plan clinical supply lead immunotherapeutic shall prepared described submission manufacturing update plan title master cell bank clinical supply shall vest with aduro them purpose other than satisfy obligation under this agreement aduro shall ensure that clinical supply supplied under submission manufacturing update plan shall meet release specification mutually agreed aduro manufactured accordance with gmps without limiting foregoing aduro shall cooperate with implementation remediation plan described agreement addition aduro janssen supply chain quality organization shall introduce into quality agreement contemplated agreement such provision necessary that will also have direct oversight both nbsp aduro quality control quality assurance with respect master cell bank nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign manufacturing licensed immunotherapeutics subsequent submission manufacturing update plan activity upon request aduro shall provide reasonable cooperation assist establishing manufacturing relationship agreement with third party manufacture licensed immunotherapeutics component thereof including technology transfer activity from aduro third party manufacturer manufacturer selected provided that cost incurred with respect such agreement relationship with third party shall borne solely table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign technology transfer cost cost such technology transfer activity shall other than technology transfer activity contemplated technology transfer plan party shall agree writing plan budget necessary implement technology transfer activity contemplated this section nbsp taking into account reasonable availability aduro resource table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign platform update commencing after second year anniversary closing date aduro shall provide following schedule charge subject section nbsp annual update aduro listeria monocytogenes based technology platform each platform update consisting information forth platform update schedule platform update hereunder shall provided same schedule platform update defined agreement under agreement appropriate consolidated into single report table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign research development commercialization licensed immunotherapeutics table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign general except otherwise expressly provided this agreement including submission manufacturing update plan subject obligation herein shall have decision making authority control responsibility with respect development manufacturing commercialization licensed immunotherapeutics table style margin margin bottom margin left font size font family time roman without limiting foregoing aduro have considered together licensed immunotherapeutics includes portion overall plan subset planned schedule annexed this agreement each planned draft each such planned shall shared with aduro prior aduro shall permitted review comment draft comment from aduro will carefully considered material amendment each shall promptly provided aduro review discussed with aduro requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign commercially reasonable effort table style margin margin bottom text indent font size font family time roman will commercially reasonable effort develop order seek approval where approved commercialize licensed immunotherapeutics except those situation where demonstrate failure perform such development seek approval circumstance beyond reasonable control will send aduro written status report activity with respect development commercialization licensed immunotherapeutics every twelve nbsp month report will summarize material development commercialization effort expected commercialization timeline country country basis extent prepares such report country country basis aduro shall have right inquire following each calendar quarter whether material change development commercialization effort have occurred since last annual report will commercially reasonable effort provide aduro oral written summary promptly thereafter without limiting foregoing event that order expense associated with such shall basis style margin margin bottom text indent font size font family time roman aduro belief that complying with obligation under section nbsp above shall send written notice stating same detailing what specific step aduro belief would necessary remedy such deficiency within thereafter aduro shall meet discus good faith appropriate solution should party unable agree appropriate solution progressive escalation process instituted aduro including meeting between aduro head oncology research development commercialization relevant affiliate binding mediation accordance with section nbsp style margin margin bottom text indent font size font family time roman should aduro unable agree after escalation process aduro shall have right trigger arbitration contemplated section nbsp below style margin margin bottom text indent font size font family time roman issue under section nbsp remaining unresolved after escalation described above shall resolved binding arbitration pursuant global rule accelerated commercial arbitration accelerated rule except where that procedure conflict with these provision which case these provision shall control arbitration shall conducted single neutral mutually agreed arbitrator with least nbsp year experience life science industry with appropriate expertise area which subject dispute arose provided that party unable agree appropriate arbitrator such arbitrator shall appointed institute dispute resolution from health care nbsp life science panel distinguished neutral other panel provided such arbitrator credential referenced above expert arbitrator shall impartial independent party shall abide code ethic arbitrator commercial dispute available http ethicsandstandards each party shall provide arbitrator other party with written report setting forth position with respect substance dispute within after initial conference defined accelerated rule each party submit revised report position arbitrator within receiving other party report requested arbitrator each party shall make oral other written submission arbitrator accordance with accelerated rule provided that other party shall have right present during oral submission arbitration under this section nbsp arbitrator party shall their diligent effort resolve such dispute within after selection arbitrator arbitrator ruling shall final binding upon party provided that party challenge such ruling solely event misconduct arbitrator style margin margin bottom text indent font size font family time roman rendering decision arbitrator shall specify what obligation failed perform specify those action which should undertake satisfy obligation forth section nbsp arbitrator determines that obligation under section nbsp shall then have option nbsp agreeing reasonable effort perform specified step forth arbitrator nbsp revising definition territory herein exclude some such country from this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman nbsp seeking sublicensee either globally country specific basis necessary perform specified step some such country except expressly provided herein there shall obligation development commercialization other diligence either implied construed upon party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign financials table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign license consideration right obligation forth herein shall aduro refundable license thirty million dollar aduro shall invoice promptly after closing date shall make such payment within business receipt thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign early platform update payment aduro shall have right sole option provide platform update described section nbsp sooner than following closing date later than following execution date platform early update period aduro provide platform update during platform early update period long such early platform update meet criterion forth platform update schedule will aduro refundable early platform update payment aduro shall invoice promptly after delivery platform update shall make such payment within receipt thereof accordance with invoice procedure schedule notwithstanding foregoing shall have right accelerate window such early platform update upon written notice aduro which case early platform early update period shall reset extend from following date aduro receipt such notice until date that following date aduro receipt such notice inclusive event aduro confirms writing that will provide such early platform update during applicable period whether accelerated pursuant previous sentence nbsp aduro shall deemed breach agreement account such omission nbsp shall have obligation make such payment regardless later platform update party shall meet person teleconference during first week platform early update period whether accelerated discus plan early platform update table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign submission manufacturing update plan payment subject term condition this agreement consideration aduro performance submission manufacturing update plan shall cause paid aduro each following refundable creditable payment upon achievement each following event table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman payment performance submission manufacturing update plan valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid payment valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp table style margin margin bottom margin left font size font family time roman achievement event forth above shall accelerate other event that precede such event such case event previously achieved will deemed have been achieved purpose under this agreement time achievement subsequent event style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign milestone payment table style margin margin bottom text indent font size font family time roman subject term condition this agreement partial consideration right license granted aduro hereunder shall cause paid aduro each following refundable creditable milestone payment upon achievement each following milestone event affiliate sublicensees with respect licensed immunotherapeutics avoidance doubt each milestone payment listed below shall payable only once shall paid style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman subsequent occurrence same event with respect subsequent licensed immunotherapeutic addition each first commercial sale milestone such milestone would only payable connection with first commercial sale after regulatory approval such licensed immunotherapeutic would trigger such milestone therefore licensed immunotherapeutic result purpose this section nbsp style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center valign bottom width width valign bottom width style font family time roman font size valign bottom colspan nowrap style border bottom solid width font size font family time roman milestone event valign bottom nbsp nbsp valign bottom align center style border bottom solid milestone nbsp payment bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center valign bottom width width valign bottom width style font family time roman font size valign bottom colspan nowrap style border bottom solid width font size font family time roman milestone event valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman milestone payment bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom nbsp additional nbsp nbsp nbsp prior nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom nbsp additional nbsp nbsp nbsp prior nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom nbsp additional nbsp nbsp nbsp prior nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center valign bottom width width valign bottom width style font family time roman font size valign bottom colspan nowrap style border bottom solid width font size font family time roman milestone event valign bottom nbsp nbsp valign bottom align center style border bottom solid milestone nbsp payment bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center valign bottom width width valign bottom width style font family time roman font size valign bottom colspan nowrap style border bottom solid width font size font family time roman milestone event valign bottom nbsp nbsp valign bottom align center style border bottom solid milestone nbsp payment bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom table style margin margin bottom text indent font size font family time roman shall notify aduro promptly writing event within achievement milestone event aduro shall invoice promptly upon receipt such notice shall make applicable refundable milestone payment forth above within receipt thereof style margin margin bottom text indent font size font family time roman achievement certain milestone forth above achieved milestone shall accelerate certain specified other milestone that would usually always achieved advance such achieved milestone skipped milestone such case associated skipped milestone previously concurrently achieved will deemed have been achieved purpose under this agreement time achievement achieved milestone only skipped milestone forth below table each achieved milestone will accelerated deemed have been achieved without actually being achieved style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap align center style border bottom solid width font size font family time roman align center achieved milestone valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center associated skipped milestone style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center style font family time roman font size valign align center valign bottom nbsp nbsp valign align center table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center style font family time roman font size valign align center valign bottom font style font size nbsp nbsp font valign align center table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign royalty relating licensed immunotherapeutics table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign royalty amount partial consideration exclusive license provided herein subject limitation below shall aduro royalty aggregate sale licensed immunotherapeutics each calendar year during royalty term applicable licensed immunotherapeutic licensed immunotherapeutic basis follows table style margin margin bottom margin left text indent font size font family time roman sale licensed immunotherapeutic calendar year than aggregate worldwide that portion such sale occurred united state that portion such sale occurred outside united state each case determined accordance with section nbsp below style margin margin bottom margin left text indent font size font family time roman sale licensed immunotherapeutic calendar year between aggregate worldwide that portion such sale occurred united state that portion such sale occurred outside united state each case determined accordance with section nbsp below style margin margin bottom margin left text indent font size font family time roman sale licensed immunotherapeutic calendar year between aggregate worldwide that portion such sale occurred united state that portion such sale occurred outside united state each case determined accordance with section nbsp below style margin margin bottom margin left text indent font size font family time roman sale licensed immunotherapeutic calendar year greater than aggregate worldwide that portion such sale occurred united state that portion such sale occurred outside united state each case determined accordance with section nbsp below style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign territorial ration order determine what amount sale each tier shall applied sale within united state versus outside united state such tier shall rated ratio which global sale applicable calendar quarter divided between sale united state sale outside united state example given calendar quarter sale were made globally such sale occurred united state then would royalty under tier described section nbsp rate forth united state rate forth outside unites state with respect remaining would royalty under tier described section nbsp such sale rate forth united state such sale rate forth outside united state under tier described section nbsp such sale rate forth united state such sale rate forth outside united state table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign royalty term royalty amount forth above shall payable each licensed immunotherapeutic product product country country basis from date first commercial sale such licensed immunotherapeutic such country until later nbsp twelve nbsp year from date first commercial sale such licensed immunotherapeutic such country nbsp until last expire valid claim aduro patent that cover composition matter such licensed immunotherapeutic only approved method such licensed immunotherapeutic such country nbsp expiry data exclusivity right with respect such licensed immunotherapeutic such country royalty term table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign period ration event that result change royalty rate payable occurs during calendar quarter such patent expiry third anniversary first commercial sale licensed immunotherapeutic practical determine with certainty which relevant sale took place before which sale took place after such event then sale such calendar quarter affected such change shall rated over such calendar quarter based upon number business relevant country country territory such calendar quarter before occurrence such event compared total business such country country such calendar quarter table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign royalty rate adjustment table style margin margin bottom text indent font size font family time roman valid claim licensed immunotherapeutic licensed immunotherapeutic country country basis royalty rate specified section nbsp above shall reduced nbsp applicable royalty payable affiliate sublicensees pursuant section nbsp nbsp applicable royalty payable affiliate sublicensees pursuant section nbsp each case with respect sale licensed immunotherapeutic country which there valid claim such licensed immunotherapeutic such country style margin margin bottom text indent font size font family time roman third party license party acknowledge agree that enter into third party license reasonably useful necessary exploitation licensed immunotherapeutics such event shall subject section nbsp below entitled deduct from royalty otherwise payable aduro respect sale country country respect which obtained such license applicable royalty payment actually paid affiliate sublicensees such third party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman pursuant such third party license relevant period respect sale such licensed immunotherapeutic such country country notwithstanding foregoing deduction taken third party payment respect style margin margin bottom text indent font size font family time roman compulsory license time third party country shall under right compulsory license manufacture sell offer sell import licensed immunotherapeutic then with respect royalty that would payable hereunder reduce royalty rate sale such country such licensed immunotherapeutic compulsory royalty rate style margin margin bottom text indent font size font family time roman cumulative adjustment exclusion notwithstanding anything contrary herein under circumstance will aggregate royalty aduro calendar year country with respect given licensed immunotherapeutic reduced application reduction offset forth this section nbsp nbsp with respect royalty amount under section nbsp aggregate amount greater than reduction permitted under section nbsp nbsp with respect royalty amount under section aggregate amount greater than royalty amount that would otherwise payable assuming deduction aduro pursuant section style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign payment term table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign currency payment related matter table style margin margin bottom text indent font size font family time roman payment under this agreement will made united state dollar style margin margin bottom text indent font size font family time roman purpose computing royalty payment sale made currency other than united state dollar such sale shall converted into united state dollar using currency hedge rate style margin margin bottom text indent font size font family time roman upcoming calendar year shall provide writing aduro later than business after currency hedge rate available from gtsc which customarily october nbsp currency hedge rate used local currency each country territory nbsp detail such currency hedge rate style margin margin bottom text indent font size font family time roman currency hedge rate will remain constant throughout upcoming calendar year shall currency hedge rate convert sale dollar purpose calculating royalty style margin margin bottom text indent font size font family time roman royalty shall paid through wire transfer bank account designated aduro style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign late payment fails payable under this agreement within business after date payment shall interest such period from including date date actual payment rate that interest will accrue from basis actual number elapsed year shall payable demand compounded quarterly arrears table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign report payment shall make royalty payment within following each calendar quarter furthermore each royalty payment shall accompanied written report showing sale royalty amount payable during relevant calendar quarter each calendar year party shall calculate whether there been underpayment overpayment during course that calendar year event that overpayment occurred shall entitled offset such overpayment against royalty payable aduro first calendar quarter subsequent calendar year event that underpayment occurred shall equal such underpayment aduro addition royalty paid first calendar quarter subsequent calendar year prepared table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign internal purpose will provide aduro within first applicable calendar quarter such shall reasonably based information then currently available binding will responsible aduro shall have liability with respect thereto aduro acknowledges that being provided solely aduro convenience table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign record each party shall keep cause affiliate sublicensees keep true accurate book record consistent with relevant accounting standard sufficient detail enable payment subject reimbursement determined until third calendar year following calendar year which such book record pertain longer required applicable upon request party more often than once calendar year such party expense except otherwise provided herein designate independent public accountant acceptable other party such acceptance unreasonably withheld conditioned delayed review such book record verify accuracy payment made payable hereunder during preceding three nbsp calendar year report independent public accountant provided with other party prior distribution auditing party such that other party provide independent public accountant with justifying remark inclusion report prior sharing conclusion such independent public audit final audit report will shared with aduro same time specify whether amount paid party pursuant thereto were correct incorrect amount underpayment overpayment auditing party shall promptly underpayment auditing party together with interest calculated manner provided section nbsp independent accountant discovers inaccuracy that caused underpayment auditing party auditing party more relevant audit period expense accountant shall borne auditing party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign further payment obligation shall have payment obligation aduro except expressly forth this agreement except otherwise expressly agreed writing aduro solely responsible royalty milestone other payment consideration third party result development commercialization licensed immunotherapeutics including consideration pursuant agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign table style margin margin bottom text indent font size font family time roman will make payment aduro under this agreement without deduction withholding except extent that such deduction withholding required effect time payment style margin margin bottom text indent font size font family time roman required withheld amount payable under this agreement will promptly paid behalf aduro appropriate governmental authority will furnish aduro with proof payment such such required withheld will expense borne aduro style margin margin bottom text indent font size font family time roman aduro will cooperate with respect documentation required taxing authority reasonably requested other secure reduction exemption rate applicable withholding closing date aduro will deliver accurate complete internal revenue service form style margin margin bottom text indent font size font family time roman duty withhold connection with payment made aduro under this agreement failed withhold such were assessed against paid then aduro will indemnify hold harmless from against such including interest penalty make claim with respect foregoing will comply with obligation imposed above withheld from payment aduro style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign intellectual property material table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign ownership inventorship table style margin margin bottom text indent font size font family time roman license other than expressly provided this agreement neither party grant right title interest information patent other intellectual property right controlled such party affiliate other party affiliate style margin margin bottom text indent font size font family time roman ownership technology style margin margin bottom margin left text indent font size font family time roman between party aduro shall retain right title interest aduro intellectual property style margin margin bottom margin left text indent font size font family time roman between party aduro shall retain right title interest intellectual property including patent conceived discovered developed otherwise made reduced practice behalf aduro affiliate either alone jointly with others during course furtherance direct result development manufacturing commercialization licensed immunotherapeutics hereunder that name inventor having obligation assignment time such intellectual property conceived discovered developed otherwise made collectively herein aduro project style margin margin bottom margin left text indent font size font family time roman except forth subsection nbsp above between party shall retain right title interest intellectual property including patent conceived discovered developed otherwise made reduced practice behalf affiliate either alone jointly with others during course furtherance direct result development manufacturing commercialization licensed immunotherapeutics hereunder that name inventor having obligation assignment aduro time such intellectual property conceived discovered developed otherwise made collectively herein project style margin margin bottom margin left text indent font size font family time roman party shall jointly intellectual property including patent conceived discovered developed otherwise made reduced practice during course furtherance direct result development manufacturing commercialization licensed immunotherapeutics hereunder that name inventor having obligation assignment aduro inventor having obligation assignment time such intellectual property conceived discovered developed otherwise made collectively herein joint project style margin margin bottom margin left text indent font size font family time roman avoidance doubt aduro project aduro right joint project shall treated aduro intellectual property under this agreement extent such aduro project joint project relates licensed immunotherapeutic material likewise project right joint project shall treated know patent appropriate under this agreement extent such project joint project useful reasonably necessary exploitation licensed immunotherapeutic project right joint project shall treated improvement aduro core technology under this agreement extent enhancement improvement modification aduro core technology style margin margin bottom margin left text indent font size font family time roman purpose this section nbsp inventorship shall determined accordance with applicable united state intellectual property regardless country which such intellectual property conceived discovered developed otherwise made style margin margin bottom margin left text indent font size font family time roman with regard intellectual property conceived discovered developed otherwise made reduced practice during course furtherance direct result style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman development manufacturing commercialization licensed immunotherapeutics each party shall promptly notify other party such intellectual property which becomes aware party shall confer timely manner order take such action reasonably necessary protect such intellectual property including limited filing patent protection style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign filing prosecution maintenance defense aduro core patent table style margin margin bottom text indent font size font family time roman aduro shall have initial right responsibility filing prosecuting maintaining enforcing defending aduro core patent including intellectual property jointly owned party accordance with section nbsp that aduro core patent sole cost with commercially reasonable diligence aduro shall provide with timely copy material communication from applicable patent office concerning prosecution aduro core patent provide opportunity reasonably advance filing deadline comment thereon consult with aduro about consider good faith request suggestion concerning such prosecution style margin margin bottom text indent font size font family time roman least calendar prior applicable date national stage filing international patent application filed under patent cooperation treaty that aduro core patent aduro shall provide with list country region into which aduro intends file such national stage application this list shall include least united state european patent office japan each which filed either directly through such international patent application request that aduro file such national stage application more additional country with filing cost those additional country including required translation cost expense except provided section nbsp aduro shall retain sole right responsibility prosecuting maintaining defending aduro core patent filed under this section nbsp style margin margin bottom text indent font size font family time roman either party learns nbsp actual suspected commercially material infringement aduro core patent covering licensed immunotherapeutic third party nbsp unauthorised commercially material third party aduro know relating licensed immunotherapeutic shall promptly notify other party representative aduro shall confer determine good faith appropriate course action enforce defend such intellectual property right accordance with section nbsp style margin margin bottom text indent font size font family time roman upon notice that third party commenced action oppose revoke cancel invalidate aduro core patent covering licensed immunotherapeutic aduro shall confer determine good faith appropriate course action enforce defend such intellectual property right accordance with section nbsp style margin margin bottom text indent font size font family time roman event that aduro decides with respect country file prosecute abandon lapse aduro core patent during term aduro shall notify such decision least calendar prior expiration deadline relating such activity shall have option obligation assume responsibility writing within such notice prosecuting maintaining defending such aduro core patent sole expense failure provide such written notice shall considered decision other party that will exercise such option such option shall immediately terminate assuming exercise option shall keep aduro informed direct cost incurred prosecuting maintaining defending such aduro core patent style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign filing prosecution maintenance defense licensed immunotherapeutic specific patent patent right improvement aduro core technology table style margin margin bottom text indent font size font family time roman shall have initial right responsibility filing prosecuting maintaining enforcing defending licensed immunotherapeutic specific patent including intellectual property jointly owned party accordance with section nbsp that licensed immunotherapeutic specific patent patent right improvement aduro core technology style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman core improvement patent sole cost with commercially reasonable diligence shall provide aduro with timely copy material communication from applicable patent office concerning prosecution licensed immunotherapeutic specific patent core improvement patent provide aduro opportunity reasonably advance filing deadline comment thereon consult with about consider good faith request suggestion aduro concerning such prosecution style margin margin bottom text indent font size font family time roman least calendar prior applicable date national stage filing international patent application filed under patent cooperation treaty that licensed immunotherapeutic specific patent core improvement patent shall provide aduro with list country region into which intends file such national stage application this list shall include least united state european patent office japan each which filed either directly through such international patent application aduro request that file such national stage application more additional country with filing cost those additional country including required translation cost aduro expense except provided section nbsp shall retain sole right responsibility prosecuting maintaining defending licensed immunotherapeutic specific patent core improvement patent filed under this section nbsp style margin margin bottom text indent font size font family time roman either party learns nbsp actual suspected commercially material infringement licensed immunotherapeutic specific patent core improvement patent third party shall promptly notify other party representative aduro shall confer determine good faith appropriate course action enforce such intellectual property right accordance with section nbsp style margin margin bottom text indent font size font family time roman upon notice that third party commenced action oppose revoke cancel invalidate licensed immunotherapeutic specific patent core improvement patent case aduro shall confer determine good faith appropriate course action enforce defend such intellectual property right accordance with section nbsp style margin margin bottom text indent font size font family time roman event that decides with respect country prosecute abandon lapse licensed immunotherapeutic specific patent core improvement patent during term shall notify aduro such decision least calendar prior expiration deadline relating such activity aduro shall have right obligation assume responsibility prosecuting maintaining defending such licensed immunotherapeutic specific patent core improvement patent aduro sole expense hereby grant aduro accepts fully paid royalty bearing exclusive even sublicensable license under right licensed immunotherapeutic specific patent core improvement patent which aduro assumes responsibility under this section nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign patent term extension patent certification notice table style margin margin bottom text indent font size font family time roman shall responsible determining strategy applying extension term patent which responsibility prosecute maintain defend under this section nbsp such under drug price competition patent term restoration hereinafter supplementary certificate protection member state european union other similar measure other country requested aduro shall apply reasonable effort obtain such extension should require sublicensees hereunder apply aduro hereby give permission which case aduro agrees cooperate with sublicensee applicable exercise such authorization shall execute such document take such additional action reasonably request connection therewith aduro agree cooperate with another obtaining patent extension hereunder directed style margin margin bottom text indent font size font family time roman shall responsible determining strategy with respect certification notice patent enforcement procedure regarding patent which responsibility prosecute maintain defend under this section nbsp under biologics price competition innovation style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman hereinafter bpcia aduro shall cooperate reasonably requested manner consistent with section nbsp this section nbsp aduro hereby authorizes nbsp provide connection with bpcia list patent that include aduro core patent that applicable licensed immunotherapeutics under bpcia nbsp except otherwise provided this agreement exercise right exercisable patent owner under bpcia nbsp exercise right that exercisable reference product sponsor under bpcia including nbsp providing list patent that relate licensed immunotherapeutics including aduro core patent nbsp engaging patent resolution provision bpcia with regard licensed immunotherapeutic specific patent nbsp determining which licensed immunotherapeutic specific patent will subject immediate patent infringement action under bpcia provided that with respect exercise right under bpcia shall consult with representative aduro designated aduro writing qualified receive confidential information pursuant bpcia with respect exercise right exercisable reference product sponsor including providing such representative with timely copy material correspondence relating such matter providing such representative opportunity reasonably advance related action comment thereon consult with consider good faith request suggestion aduro with respect such matter style margin margin bottom text indent font size font family time roman event that desire apply extension patent which aduro responsibility prosecute maintain defend under this section nbsp under supplementary certificate protection member state european union other similar measure other country utilize such patent purpose engaging patent resolution provision bringing patent infringement action under bpcia party shall meet good faith discus strategy such activity provided that aduro shall obligated agree such patent such activity style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign separation aduro core patent licensed immunotherapeutic specific patent party acknowledge that certain patent application owned aduro jointly aduro that subject this section nbsp contain specification that support claim that fall within definition aduro core patent well claim that fall within definition licensed immunotherapeutic specific patent extent possible party shall cooperate divide such application into separate daughter patent application that claim common priority such that daughter patent application that fall within aduro core patent will contain claim falling within licensed immunotherapeutic specific patent daughter patent application that fall within licensed immunotherapeutic specific patent will contain claim falling within aduro core patent aduro shall have sole right responsibility filing prosecuting maintaining defending daughter patent application that aduro core patent accordance with section nbsp shall have sole right responsibility filing prosecuting maintaining defending daughter patent application that licensed immunotherapeutic specific patent accordance with section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign mechanism enforcement defense table style margin margin bottom text indent font size font family time roman party asserting right enforce defend aduro core patent licensed immunotherapeutic specific patent under this agreement controlling party shall keep other party reasonably informed during course legal action related such enforcement defense action shall consult with such other party before taking major step during conduct such action other party shall provide reasonable cooperation controlling party connection with such action including being named party such action required standing purpose style margin margin bottom text indent font size font family time roman controlling party action shall take position with respect compromise settle such action that reasonably likely directly adversely affect scope validity enforceability aduro core patent licensed immunotherapeutic specific patent without other party prior written consent unreasonably withheld conditioned delayed style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman party having right controlling party action shall provide prompt written notice other party sufficiently timely manner that such action will prejudiced style margin margin bottom margin left text indent font size font family time roman intend pursue action pursuant this section nbsp take such other action required permitted under bpcia preserve ability prosecute potential action including such action contemplated under section nbsp style margin margin bottom margin left text indent font size font family time roman commenced such action within earlier nbsp calendar after notice infringement nbsp calendar prior time limit forth under applicable filing such action taken such other action style margin margin bottom margin left text indent font size font family time roman ceased intends cease diligently pursue such action such other action style margin margin bottom font size font family time roman upon receipt such written notice other party shall have option become controlling party other party shall respond with written notice within business indicating intends exercise such option upon which such other party shall become controlling party take action expense enforce take such other action with respect such action including initiating action taking over prosecution such action initiated previously failure provide such written notice shall considered decision other party that will exercise such option such option shall immediately terminate style margin margin bottom text indent font size font family time roman recovery from action shall shall style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign infringement claim third party table style margin margin bottom text indent font size font family time roman manufacture development commercialization licensed immunotherapeutic result claim threatened claim third party against party hereto patent infringement other violation intellectual property right party first having notice thereof shall promptly notify other writing notice shall forth fact claim reasonable detail style margin margin bottom text indent font size font family time roman affiliate sublicensees shall have right obligation defend suit claiming that development manufacture commercialization licensed immunotherapeutic infringes patent other intellectual property right third party aduro will cooperate assist such litigation expense without prejudice right pursue indemnity claim lieu defending suit provided this section nbsp cost damage awarded third party pursuant such suit shall borne retained case solely aduro shall reasonable request sole expense assist defense such action cost incurred aduro providing assistance affiliate sublicensees shall borne solely style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign licensed immunotherapeutic material connection with aduro transfer licensed immunotherapeutic material agrees that licensed immunotherapeutic material will used other than connection with this agreement such licensed immunotherapeutic material shall modified changed manner create product other than licensed immunotherapeutics extent practicable shall secure record identity person given access licensed immunotherapeutic material reasonably track location master cell bank promptly report aduro unauthorized that discovered shall ensure that third party given access licensed immunotherapeutic material shall agree bound writing term onerous those herein table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notice challenge aduro patent nbsp event affiliate intends assert forum that aduro patent nbsp invalid nbsp affiliate applicable nbsp will than nbsp nbsp nbsp prior nbsp nbsp making nbsp nbsp such nbsp assertion provide nbsp aduro nbsp nbsp summary nbsp written nbsp disclosure nbsp ground then known nbsp affiliate applicable disclosure such assertion table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign with such nbsp disclosure will provide aduro with copy publicly available document publication upon which affiliate applicable intends rely support such assertion within aduro receipt disclosure aduro request aduro shall meet discus disclosure such disclosure discussion thereof shall without prejudice shall treated settlement discussion under rule federal rule evidence disclosure made under this section nbsp discussion between party hereunder shall construed admission kind neither disclosure party discussion exchange information hereunder shall used aduro basis assertion declaratory judgment action other cause action aduro agrees assert cause action against affiliate sublicensees relating such aduro patent other than enforce term hereof until least following conclusion such discussion table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidentiality table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidentiality obligation party agree that term this agreement year thereafter either party that receives receiving party from other party disclosing party proprietary information pursuant this agreement collectively confidential information shall keep confidential shall publish otherwise disclose shall purpose except expressly permitted this agreement such confidential information except extent that established receiving party that such confidential information nbsp already known receiving party other than under obligation confidentiality from disclosing party nbsp generally available public otherwise part public domain time disclosure receiving party nbsp became generally available public otherwise part public domain after disclosure that other than through omission receiving party breach this agreement nbsp subsequently lawfully disclosed receiving party third party nbsp shown competent evidence have been independently developed receiving party without reference confidential information received from disclosing party without breach provision this agreement nbsp information that disclosing party specifically agreed writing that receiving party disclose table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign authorized disclosure confidential information table style margin margin bottom text indent font size font family time roman receiving party disclose confidential information extent receiving party compelled disclose such information court other tribunal competent jurisdiction provided however that such case receiving party shall except where impracticable give prompt notice disclosing party that disclosing party seek protective order other remedy upon disclosing party request sole expense receiving party shall provide reasonable assistance disclosing party seeking such protective order other remedy event receiving party shall disclose only that portion confidential information that opinion legal counsel legally required disclosed will exercise reasonable effort ensure that such information disclosed will accorded confidential treatment style margin margin bottom text indent font size font family time roman extent reasonably necessary fulfil obligation exercise right under this agreement either party disclose confidential information nbsp affiliate consultant advisor agent need know basis condition that such affiliate advisor consultant agent bound obligation confidentiality substantially similar those forth herein nbsp extent reasonably necessary obtain regulatory approval licensed immunotherapeutics field territory style margin margin bottom text indent font size font family time roman notwithstanding above obligation confidentiality party disclose information extent that such disclosure necessary connection with style margin margin bottom margin left text indent font size font family time roman filing prosecuting patent application style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom margin left text indent font size font family time roman prosecuting defending litigation style margin margin bottom margin left text indent font size font family time roman seeking regulatory approval licensed immunotherapeutic including regulatory approval manufacturing facility licensed immunotherapeutic style margin margin bottom margin left text indent font size font family time roman subject section nbsp below complying with applicable style margin margin bottom font size font family time roman making disclosure forth above disclosing party shall except where impracticable give such advance notice other party such disclosure requirement reasonable under circumstance except extent inappropriate case patent application will reasonable effort operate with other party order secure confidential treatment such confidential information style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign required security filing event either party proposes file with security exchange commission security regulator state other jurisdiction registration statement other disclosure document that describes refers term condition this agreement under security amended security exchange amended other applicable such party shall notify other party such intention shall provide such other party with copy relevant portion draft proposed filing soon reasonably practicable event than business prior such filing party making such filing shall reasonable effort obtain confidential treatment term condition this agreement that such other party request kept confidential event financial term shall only disclose confidential information that advised counsel legally required disclosed required disclosed such notice shall required under this section nbsp description reference this agreement contained proposed filing been included previous filing made either party hereunder otherwise approved other party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign publication subject term condition this section nbsp avoidance doubt aduro publish present data result generated during collaboration term relating activity conducted under submission manufacturing update plan scientific journal scientific conference subject prior review comment aduro such publication includes aduro confidential information follows shall provide aduro with opportunity review such proposed abstract manuscript presentation delivering copy thereof aduro than before intended submission publication presentation aduro shall have after receipt such abstract manuscript presentation which notify writing specific objection disclosure confidential information aduro event that aduro object disclosure writing within such period agrees submit publication abstract make presentation containing objected information until party have agreed modify such information shall delete from proposed disclosure aduro confidential information upon reasonable request aduro once such abstract manuscript accepted publication will provide aduro with copy final version manuscript abstract avoidance doubt data result specific licensed immunotherapeutics shall deemed confidential information publication with respect thereto shall sole discretion addition with respect activity conducted outside submission manufacturing update plan publication relating licensed immunotherapeutics submitted publication affiliate clinical other activity subject this section nbsp except extent that aduro confidential information related aduro platform technology incorporated therein table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign public announcement press release press release deemed agreed upon party attached this agreement press release schedule which press release shall released time mutually agreed party neither party shall originate other publicity news release public announcement written oral whether public press stockholder otherwise table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign relating this agreement including existence subject matter which relates performance under term amendment hereto performance hereunder without prior written consent other party save only such announcement that otherwise agreed party such announcement shall brief factual except otherwise provided herein party decides make announcement required applicable shall reasonable effort give other party least business advance notice where possible text announcement that other party shall have opportunity comment upon announcement extent that receiving party reasonably request deletion confidential information material disclosing party shall delete such information unless opinion disclosing party legal counsel such confidential information legally required disclosed table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign publication clinical trial result unless otherwise agreed writing party agree that shall have right disclose nbsp each clinical trial conducted pursuant submission manufacturing update plan clinicaltrials other similar registry nbsp result such clinical trial clinicalstudyresults other registry with requirement consistent with registration publication guideline international committee medical journal editor extent required table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign adverse event reporting table style margin margin bottom text indent font size font family time roman reporting party recognize that designee holder regulatory approval application except contemplated submission manufacturing update plan regulatory approval territory licensed immunotherapeutics required submit information file report regulatory authority licensed immunotherapeutics which under clinical investigation proposed marketing marketed territory party also recognize that aduro designee holder regulatory approval application regulatory approval territory other product based aduro live attenuated double deleted ladd listeria monocytogenes strain required submit information file report regulatory authority such other product which under clinical investigation proposed marketing marketed territory each party will will require affiliate sublicensees report adverse event with respect their respective product extent required accordance with applicable style margin margin bottom text indent font size font family time roman safety agreement nbsp pursuant agreement each party assigned representative such representative have conducted first meeting contemplated agreement agree process procedure supplementing sharing adverse event information documented pharmacovigilance agreement contemplated under agreement nbsp within time period agreed party pursuant agreement party shall negotiate good faith enter into pharmacovigilance agreement governing safety data exchange procedure regarding coordination collection investigation reporting exchange information concerning adverse event with respect party activity under both agreement this agreement comply with applicable including with respect clinical trial conducted behalf each party affiliate sublicensees style margin margin bottom text indent font size font family time roman safety liaison nbsp party shall designate safety liaison responsible communicating with other party regarding reporting adverse event extent required agreed pharmacovigilance agreement with respect their respective product style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign representation warranty table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign representation warranty covenant both party table style margin margin bottom margin left font size font family time roman each party represents warrant other party execution date closing date that style margin margin bottom text indent font size font family time roman such party duly organized validly existing good standing under jurisdiction incorporation full corporate power authority enter into this agreement carry provision hereof style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman such party taken necessary action part authorize execution delivery this agreement performance obligation hereunder style margin margin bottom text indent font size font family time roman this agreement been duly executed delivered behalf such party constitutes legal valid binding obligation enforceable against accordance with term hereof style margin margin bottom text indent font size font family time roman execution delivery performance this agreement such party including grant right other party pursuant this agreement best knowledge such party nbsp conflict with result violation default under agreement instrument understanding oral written which affiliate party which affiliate bound nbsp conflict with right granted such party third party breach obligation that such party third party nbsp violate applicable court governmental body administrative other agency having jurisdiction over such party style margin margin bottom text indent font size font family time roman government authorization consent approval license exemption filing registration with court governmental department commission board bureau agency instrumentality domestic foreign under applicable rule regulation currently effect necessary connection with transaction contemplated this agreement performance obligation under this agreement style margin margin bottom text indent font size font family time roman employee officer contractor consultant have rendered will render service relating licensed immunotherapeutics either nbsp have executed agreement requiring assignment such party right title interest their invention discovery they have invented otherwise discovered generated during course result their association with such party whether patentable such party sole owner thereof nbsp such party employee officer contractor consultant shall have executed such agreement nbsp subject legal requirement assign right title interest invention they have invented otherwise discovered generated during course result their association with such party such party nbsp assignment such employee officer contractor consultant such invention such party occurs operation style margin margin bottom text indent font size font family time roman employee officer contractor consultant have rendered will render service relating licensed immunotherapeutics either nbsp have executed agreement obligating each such employee officer contractor consultant maintain confidential confidential information such party nbsp such party employee officer contractor consultant shall have executed such agreement such employee officer contractor consultant subject operation applicable professional requirement maintain confidential confidential information such party style margin margin bottom text indent font size font family time roman neither such party employee officer best knowledge subcontractor consultant have rendered will render service relating licensed immunotherapeutics nbsp ever been debarred subject debarment convicted crime which entity person could debarred under subject similar sanction nbsp knowledge party ever been under indictment crime which person entity could debarred style margin margin bottom text indent font size font family time roman such party shall conduct activity hereunder accordance with applicable style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign representation warranty covenant aduro table style margin margin bottom text indent font size font family time roman aduro represents warrant execution date closing date that style margin margin bottom text indent font size font family time roman aduro owns otherwise control aduro patent forth aduro patent schedule which schedule differentiates between aduro patent that owned aduro affiliate aduro patent that controlled aduro through license otherwise style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman aduro patent subject interference opposition proceeding nbsp there pending threatened action suit proceeding claim third party challenging ownership right validity scope such aduro patent style margin margin bottom text indent font size font family time roman aduro received written notice from third party asserting ownership right aduro know nbsp aduro aware pending threatened action suit proceeding claim third party asserting that aduro infringing otherwise violating patent trade secret other proprietary right third party connection with licensed immunotherapeutics style margin margin bottom text indent font size font family time roman there agreement between aduro third party that would result royalty milestone other payment consideration being from such third party result development commercialization licensed immunotherapeutics style margin margin bottom text indent font size font family time roman aduro granted right license third party under aduro intellectual property that would conflict interfere with right license granted hereunder that result narrowing definition aduro intellectual property control limitation aduro will future grant right license third party under aduro intellectual property that would conflict interfere with right license granted hereunder without express written consent style margin margin bottom text indent font size font family time roman except forth third party patent schedule aduro knowledge practice aduro know aduro patent included among aduro core technology either party covered third party patent involve misappropriation third party information otherwise violate third party intellectual property right style margin margin bottom text indent font size font family time roman reference knowledge above provision this article mean style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnification insurance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnification shall indemnify defend hold harmless aduro affiliate their respective officer director employee agent licensors their respective successor heir assigns representative from against damage loss liability cost including reasonable legal expense cost litigation reasonable attorney judgment whether money equitable relief kind loss with respect third party claim suit proceeding claim extent arising nbsp nbsp nbsp each case except extent such loss claim subject aduro indemnity obligation forth section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnification aduro aduro shall indemnify defend hold harmless affiliate their respective officer director employee agent licensors their respective successor heir assigns representative from against loss with respect claim extent arising nbsp nbsp nbsp each case except extent such loss claim subject indemnity obligation forth section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign process indemnification claim which indemnification applies hereunder shall referred herein indemnification claim upon occurrence event which indemnification available forth above person person collectively indemnified party that intend claim indemnification under this article shall give prompt written notice other party indemnifying party providing reasonable detail nature event basis indemnification claim further expressly stating therein that seeking table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign indemnity pursuant this agreement avoidance doubt without prejudice indemnified party obligation give prompt written notice indemnifying party knowledge event circumstance pursuant which indemnified party might seek indemnification including correspondence between party regarding matter which indemnity expressly sought shall constitute notice required this provision attorney expert consultant expense incurred indemnified party prior proper notice shall sole responsibility such party provided however that failure such timely notice shall indemnification claim unless indemnifying party materially prejudiced failure receive such timely notice indemnifying party will have right expense with counsel choice defend contest otherwise protect against claim indemnified party will also have right obligation participate expense defense thereof with counsel choice indemnified party shall cooperate extent reasonably necessary assist indemnifying party defending contesting otherwise protesting against claim shall make available indemnifying party pertinent information under control indemnified party which information shall subject article provided that reasonable cost doing paid indemnifying party indemnifying party fails within after receipt notice nbsp notify indemnified party intent defend nbsp defend contest otherwise protect against claim fails diligently continue provide defense after undertaking indemnified party will have right obligation upon prior written notice indemnifying party defend settle satisfy claim recover cost same from indemnifying party indemnified party shall settle compromise indemnification claim without prior written consent indemnifying party indemnifying party shall settle compromise indemnification claim manner that would have adverse effect indemnified party interest including right under this agreement scope enforceability intellectual property controlled such party confidential information patent other right licensed hereunder without prior written consent indemnified party which consent each case shall unreasonably withheld conditioned delayed table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insurance during term this agreement after expiration this agreement earlier termination each party shall obtain maintain respectively sole cost expense clinical trial insurance product liability insurance amount respectively that reasonable customary pharmaceutical industry company comparable size activity respective place business each party party affiliated group with least market capitalization with annual sale latest calendar year least maintain such insurance through self insurance program such clinical trial insurance product liability insurance shall insure against liability including liability personal injury physical injury property damage each party shall provide written proof existence such insurance other party upon request table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign term termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign hart scott rodino closing date term table style margin margin bottom text indent font size font family time roman each party covenant agrees commercially reasonable effort prepare make appropriate timely filing under title hart scott rodino antitrust improvement purpose section amended rule promulgated thereunder within business after execution date party agree cooperate antitrust clearance process furnish promptly federal trade commission antitrust division department justice antitrust division additional information reasonably requested them connection with such filing each party will responsible connection with filing described this section aduro shall have right assign license right licensed immunotherapeutics third party during waiting period referred below provided that aduro shall have right enter into agreement with third party preparation style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman party collaborative activity after closing date this section nbsp shall bind party upon execution date remaining provision this agreement shall become effective until date which waiting period provided waiting period terminated expired without action government agency challenge termination earlier notification date party government agency that agency intends take action under which date shall closing date style margin margin bottom text indent font size font family time roman event that antitrust clearance from antitrust division obtained within after execution date such other date party agree agreement terminated either party written notice other event provision agreement need deleted substantially revised order obtain regulatory clearance party will negotiate good faith provision which economic effect scope right sufficiently similar provision that reasonably assumed that party would have entered into agreement with such provision style margin margin bottom text indent font size font family time roman subject section nbsp this agreement shall come into force effect closing date shall unless terminated earlier accordance with term continue force effect until aduro patent have expired thereafter licensed immunotherapeutic licensed immunotherapeutic country country basis until last expire royalty term each such country with respect each such licensed immunotherapeutic period during which this agreement force hereinafter term style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign termination event material breach subject article except provided section nbsp event material uncured breach other party breaching party terminate case modify permitted under section nbsp this agreement right license granted hereunder providing sixty nbsp calendar prior written notice other party detailing specific obligation under this agreement alleged have been breached manner such alleged breach step that need taken order remedy such breach unless other party cure such breach ground termination within period such notice provided that there good faith dispute with respect existence such material breach time cure will extended until such time dispute resolved pursuant article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign termination agreement insolvency either party addition other remedy available equity terminate case modify accordance with section nbsp this agreement entirety notice other party event nbsp other party shall have become bankrupt shall have made assignment benefit creditor nbsp there shall have been appointed trustee receiver other party substantial part property nbsp case proceeding covered clause nbsp shall have been commenced other action taken against other party bankruptcy seeking reorganisation liquidation dissolution winding arrangement composition readjustment debt other relief under bankruptcy insolvency reorganisation other similar jurisdiction hereafter effect such event shall have continued sixty nbsp calendar undismissed unbonded undischarged table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign termination will terminate this agreement entirety country country licensed immunotherapeutic licensed immunotherapeutic basis time after closing date providing ninety nbsp prior written notice aduro following delivery notice termination pursuant this section nbsp from provision notice through effective date termination shall perform obligation hereunder regarding manufacture development commercialization affected licensed immunotherapeutic including payment milestone royalty cost incurred connection with submission manufacturing update plan other payment owed aduro other development work completed pursuant section nbsp during such period shall required initiate clinical study clinical study make further filing regulatory table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign approval other than related initiation transfer regulatory approval development commercial right aduro launch impacted licensed immunotherapeutic impacted country except each case required applicable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign cumulative right remedy right terminate this agreement shall addition lieu other right remedy that party giving notice termination have equity otherwise table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign effect expiration this agreement terminated earlier date then upon expiration accordance with term given country entire territory applicable shall have irrevocable perpetual fully paid royalty free exclusive license field such country territory applicable under aduro know with right sublicense make have made import offer sell sell licensed immunotherapeutics field table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign effect termination table style margin margin bottom text indent font size font family time roman termination bankruptcy right license granted under pursuant this agreement aduro shall otherwise deemed purpose bankruptcy code license right intellectual property defined under bankruptcy code case interpreting party agree that party licensee such right under this agreement shall retain fully exercise their right election they would have case licensor bankruptcy under bankruptcy code each party agrees during term this agreement create maintain current copy amenable copying detailed description other appropriate embodiment such intellectual property licensed other party regardless choice provision contained this agreement party expressly agree application united state particular application provision bankruptcy code right election party regarding intellectual property case licensor bankruptcy specifically right election under bankruptcy code regarding intellectual property existing outside jurisdiction licensor bankruptcy more specifically such right election regarding intellectual property existing united state party expressly submit themselves jurisdiction court united state enforcement such right election party anticipate that substantial work under this agreement will conducted united state that substantial value under this agreement will generated united state style margin margin bottom text indent font size font family time roman termination aduro material breach bankruptcy will upon termination licensed immunotherapeutic licensed immunotherapeutic licensed immunotherapeutic basis country country basis this agreement entirety pursuant section nbsp upon termination this agreement aduro pursuant section style margin margin bottom margin left text indent font size font family time roman affiliate sublicensees shall immediately cease thereafter refrain from using aduro intellectual property anywhere territory where terminates agreement under section nbsp relation given country terminated country relation terminated licensed immunotherapeutics provided however that order effect orderly transition country where licensed immunotherapeutic market party shall cooperate with respect sale existing inventory affiliate sublicensees shall retain those right necessary style margin margin bottom margin left text indent font size font family time roman except necessary comply with existing obligation including initiated clinical trial shall promptly return aduro destroy aduro discretion licensed immunotherapeutic material affiliate sublicensees possession control event such destruction provide aduro with written confirmation thereof style margin margin bottom margin left text indent font size font family time roman save expressly provided herein right hereunder relating territory where terminates agreement under section nbsp relation given country style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman terminated country terminated licensed immunotherapeutic license granted this agreement respect terminated licensed immunotherapeutic country territory shall cease terminate style margin margin bottom margin left text indent font size font family time roman written request aduro shall provide aduro copy shall transfer cause transferred aduro expense until such transfer effected such transfer possible legal aduro shall shall consent where necessary cause affiliate sublicensees consent relevant style margin margin bottom margin left text indent font size font family time roman aduro shall have license with right sublicense under existence effective date termination extent useful reasonably necessary exploit make have made import have used offer sell sell export terminated licensed immunotherapeutics solely purpose developing commercialising such licensed immunotherapeutics field territory terminated country applicable such licence shall otherwise aduro shall royalty except that then aduro shall royalty then aduro shall royalty each case sale licensed immunotherapeutics aduro affiliate sublicenses period year from first commercial sale licensed immunotherapeutic territory provision section nbsp shall apply mutatis mutandis request aduro will perform technology transfer material information covered forgoing license right which shall completed than after relevant termination notwithstanding foregoing shall have obligation provide aduro shall have right material bearing trademark trade name affiliate sublicensees style margin margin bottom text indent font size font family time roman termination modification aduro material breach aduro bankruptcy upon possible termination event pursuant section nbsp elect lieu terminating this agreement written notice aduro modify term this agreement only extent provided below event give such notice then following provision will apply style margin margin bottom margin left text indent font size font family time roman election style margin margin bottom margin left text indent font size font family time roman election aduro shall style margin margin bottom margin left text indent font size font family time roman shall style margin margin bottom margin left text indent font size font family time roman except otherwise agreed party other term condition this agreement shall continue full force effect style margin margin bottom font size font family time roman other hand give aduro notice termination rather than modification under this section nbsp hereunder then provision section nbsp shall apply style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign accrued right obligation upon expiration termination expiration termination this agreement reason shall without prejudice either party right obligation accrued prior effective date termination expiration shall deprive either party from right that agreement provides shall survive termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign survival except expressly provided herein section other provision contained this agreement that their explicit term survive expiration termination this agreement accrued right payment shall survive expiration early termination this agreement except forth this section nbsp upon termination expiration this agreement other right obligation party under this agreement terminate table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign dispute resolution governing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign dispute aduro shall devote reasonable effort amicably resolve dispute between them concerning their respective right obligation under agreement each dispute party matter within jurisdiction initially unable resolve dispute despite using reasonable effort either party written notice other have such dispute referred their respective senior management designated below their respective successor attempted resolution negotiation good faith such attempted resolution shall take place later than following receipt such notice designated management head oncology research development commercialization applicable aduro dispute that senior management resolved shall upon request party given later than after initial discussion mediated through binding mediation accordance with mediation procedure business dispute then effect except where that procedure conflict with these provision which case these provision shall prevail mediation shall conducted francisco shall attended senior executive with authority resolve dispute from each party mediator shall confer with party design procedure conclude mediation within more than calendar after initiation under circumstance commencement arbitration delayed more than calendar mediation process specified herein absent contrary agreement party statement made either party during mediation used other referred during subsequent proceeding table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign arbitration table style margin margin bottom text indent font size font family time roman binding resolution dispute that been referred senior management resolution that been resolved within after initial discussion such matter senior management shall upon referral submission either party submitted final binding resolution arbitration accordance with then current administered arbitration rule rule cpradr except where those rule conflict with these provision which case these provision control arbitration shall held francisco california style margin margin bottom text indent font size font family time roman panel panel shall consist three arbitrator chosen from panel distinguished neutral accordance with rule unless party otherwise agree selection arbitrator each whom shall lawyer with least fifteen nbsp year experience with firm corporate department each which shall have over twenty five nbsp lawyer judge court general jurisdiction event aggregate damage sought claimant stated than aggregate damage sought counterclaimant stated than neither side seek equitable relief then single arbitrator shall chosen having same qualification experience specified above each arbitrator shall impartial independent party shall abide code ethic arbitrator commercial dispute available nbsp http ethicsandstandards style margin margin bottom text indent font size font family time roman procedure arbitrator agreed event party agree upon selection arbitrator will select arbitrator follows shall provide party with list than twenty five nbsp proposed arbitrator fifteen nbsp single arbitrator selected having credential referenced above within receiving such list party shall rank least proposed arbitrator remaining initial list after exercising cause challenge party agree arbitrator following such ranking party then jointly interview five nbsp candidate three nbsp single arbitrator selected with highest combined ranking more than hour each following interview exercise peremptory challenge each panel will consist remaining three candidate arbitrator selected with highest combined ranking event these procedure fail result selection required number arbitrator shall appoint appropriate remaining number arbitrator having credential referenced section nbsp above notwithstanding foregoing arbitrator shall finally selected party required later than prior commencement arbitration proceeding style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman timing party agree cooperate nbsp attempt select arbitrator agreement within initiation arbitration including jointly interviewing candidate pursuant section nbsp nbsp meet with arbitrator within selection nbsp agree that meeting before upon procedure discovery conduct hearing that will result hearing being concluded within more than month after selection arbitrator award being rendered within conclusion hearing font style white space nowrap post hearing font briefing which briefing will completed both side within after conclusion hearing style margin margin bottom text indent font size font family time roman discovery arbitrator shall guided bound protocol disclosure document presentation witness commercial arbitration cpradr protocol party will attempt agree mode document disclosure electronic discovery witness presentation within parameter protocol party agree discovery presentation issue arbitrator shall decide presentation mode provide discovery within protocol understanding that party contemplate reasonable discovery provided that such discovery will limited that schedule forth section nbsp without undue burden party agree that discovery shall permitted order permit party obtain document format that possession custody control other party extent already possession such party arbitrator shall determine what discovery will permitted consistent with goal limiting cost time that party must expend discovery provided that arbitrator shall permit such discovery arbitrator deem necessary permit equitable resolution dispute which arbitrator discretion include request admission interrogatory arbitrator shall order require discovery against either party type scope that permitted against other party arbitrator require party seeking production document cost associated with collection review production document written evidence originally language other than english shall translated english accompanied nbsp original true copy source document nbsp original true copy translation nbsp statement signed translator translation company representative with signature notarized notary public attesting that translator translation company representative belief english language text accurate complete translation source language text arbitrator shall have power exclude evidence ground hearsay prejudice beyond probative value redundancy irrelevance award shall overturned reason ruling evidence except extent that such exclusion constitutes manifest disregard transcript testimony adduced hearing shall made shall upon request made available either party style margin margin bottom text indent font size font family time roman motion independent expert arbitrator expressly empowered decide dispositive motion advance hearing including motion dismiss motion summary judgment shall endeavor decide such motion would federal district judge sitting jurisdiction whose substantive governs forth section nbsp below arbitrator engage independent expert with experience subject matter dispute advise arbitrator final decision making authority shall remain arbitrator style margin margin bottom text indent font size font family time roman decision arbitrator arbitrator shall decide issue presented accordance with substantive state york without reference conflict principle apply principle such amiable compositeur natural justice equity arbitrator shall render written opinion stating reason upon which award based style margin margin bottom text indent font size font family time roman confidentiality cost party agree that decision arbitrator shall sole exclusive binding remedy between them regarding dispute controversy claim counterclaim presented arbitrator arbitration hearing award shall made public either party without joint consent party except extent either party required disclose such information applicable applicable rule public stock exchange enforce award accordance with section nbsp except required neither party representative witness arbitrator disclose existence content result arbitration hereunder without prior written consent both party cost such arbitration including style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman administrative arbitrator expert retained arbitrator shall shared equally party each party shall bear expense attorney incurred connection with arbitration style margin margin bottom text indent font size font family time roman court award arbitrator entered court competent jurisdiction judicial recognition decision applicable order enforcement each party apply court competent jurisdiction appropriate temporary injunctive relief avoid irreparable harm maintain status preserve subject matter arbitration each case pending resolution arbitration proceeding rule rule apply this agreement without limiting foregoing party consent jurisdiction federal district court district which arbitration held enforcement these provision entry judgment award rendered hereunder style margin margin bottom text indent font size font family time roman each party hereto waif right trial jury issue within scope agreement arbitrate forth herein style margin margin bottom text indent font size font family time roman each party hereto waif claim punitive exemplary multiplied damage from other except forth section style margin margin bottom text indent font size font family time roman each party hereto waif claim consequential damage from other except forth section style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign governing agreement shall construed respective right party hereto determined according substantive state york patent united state without regard conflict principle table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign compliance with agreement aduro represents that provided true complete correct copy agreement exists execution date including amendment thereto represents warrant that said agreement full force effect date hereof that aduro shall reasonable effort maintain said agreement full force effect with respect agreement nbsp aduro under agreement shall expire nbsp with respect such term defined agreement grant herein subject right aduro shall perform those obligation thereunder nbsp party agree that this this agreement contains provision requiring payment royalty aduro sufficient permit aduro meet royalty obligation nbsp with respect exercise sublicense furtherance aduro section nbsp agreement forth therein aduro shall inform written notice received aduro that nbsp such agreement then full force effect nbsp that nbsp aduro default said agreement event aduro receives notice from that aduro default such agreement shall table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign force majeure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign force majeure failure omission party affiliate sublicensees performance obligation under this agreement shall deemed breach agreement create liability same shall arise whole part from cause cause beyond reasonable control party affiliate sublicensees including omission government rule regulation order issued governmental authority officer department agency instrumentality thereof fire storm flood earthquake accident terrorism rebellion insurrection riot invasion strike lockout other kind force majeure each force majeure each party shall notify other party promptly writing following occurrence after becoming aware occurrence force majeure whereupon table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign party shall promptly operate mitigate effect such force majeure party suffering force majeure shall obliged reasonable effort overcome circumstance thereof event party suspends performance period three nbsp more month force majeure party shall consult good faith develop implement plan mitigating same table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign miscellaneous table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notice notice report required permitted given made under agreement party other shall writing delivered other party address indicated below such other address addressee shall have theretofore furnished writing addressor hand courier registered certified airmail postage prepaid reputable overnight courier table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign nowrap nbsp nbsp aduro valign bottom font style font size nbsp font valign valign bottom font style font size nbsp nbsp font valign style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp nbsp font valign style margin margin bottom font size font family time roman aduro biotech style margin margin bottom font size font family time roman bancroft style margin margin bottom font size font family time roman berkeley california style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp nbsp font valign attention president style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign nowrap with nbsp copy nbsp valign bottom font style font size nbsp nbsp font valign style margin margin bottom font size font family time roman arnold porter style margin margin bottom font size font family time roman park avenue style margin margin bottom font size font family time roman york york style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp nbsp font valign attention blaine templeman style font size height height colspan height colspan style font family time roman font size valign nowrap valign bottom font style font size nbsp font valign valign bottom font style font size nbsp nbsp font valign style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp nbsp font valign style margin margin bottom font size font family time roman janssen biotech style margin margin bottom font size font family time roman ridgeview drive style margin margin bottom font size font family time roman horsham pennysylvania style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp nbsp font valign attention president style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign nowrap with copy valign bottom font style font size nbsp nbsp font valign style margin margin bottom font size font family time roman chief intellectual property counsel style margin margin bottom font size font family time roman office general counsel style margin margin bottom font size font family time roman johnson johnson style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp nbsp font valign style margin margin bottom font size font family time roman johnson johnson plaza style margin margin bottom font size font family time roman brunswick jersey style margin margin bottom font size font family time roman united state america table style margin margin bottom margin left font size font family time roman notice shall effective date received addressee certified delivery reputable delivery service whichever earlier style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign waiver waiver either party breach provision hereof other party shall construed waiver succeeding breach such provision waiver provision itself table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign special indirect other loss neither party affiliate shall liable contract tort negligence breach statutory duty otherwise indirect incidental exemplary consequential special punitive damage loss profit suffered other party even determined direct damage except extent such damage required paid third party connection with judgment settlement which party responsible pursuant accordance with article hereunder table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign severability should section portion thereof agreement held invalid reason statute regulation existing future jurisdiction court competent jurisdiction legally enforceable directive governmental body such section portion thereof shall validly reformed approximate intent party nearly possible unreformable shall divisible deleted such jurisdiction agreement shall otherwise affected table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign agency relationship party under agreement that independent contractor neither party shall deemed agent other neither party authorized take action binding upon other table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign assignment this agreement shall binding upon party their respective permitted successor assigns neither party without prior written consent other party assign part right benefit under this agreement provided that such consent shall required assignment nbsp affiliate either party provided that such party shall guarantee performance assigned obligation such affiliate nbsp third party successor purchaser substantially business asset which this agreement relates whether merger sale stock sale asset other similar transaction provided that third party successor purchaser provides written notice other party that such third party agrees bound term this agreement attempted assignment delegation transfer contravention this agreement shall null void initio table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign counterpart agreement executed counterpart each which shall deemed original both together shall deemed same agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign construction this agreement shall deemed have been jointly drafted party rule strict construction shall apply against either heading cover page inserted convenience reference only shall affect their meaning interpretation used this agreement unless context otherwise requires nbsp word gender include each other gender nbsp word such herein hereof hereunder refer this agreement whole merely particular provision which such word appear nbsp word using singular shall include plural vice versa nbsp word including mean including without limitation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign further assurance each party shall duly execute deliver cause duly executed delivered such further instrument cause done such further ministerial administrative similar thing including filing such assignment agreement document instrument necessary other party reasonably request connection with this agreement carry more effectively provision purpose hereof better assure confirm unto other party right remedy under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign entire agreement term provision contained agreement constitute entire agreement between party shall supersede previous communication representation agreement understanding either oral written between party with respect subject matter hereof agreement understanding varying extending agreement shall binding upon either party hereto unless writing that specifically refers agreement signed duly authorized officer representative respective party provision agreement specifically amended thereby shall remain full force effect table style margin margin bottom font size font family time roman align center remainder page intentionally omitted style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman witness whereof aduro have executed this agreement effective date forth above style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width style font family time roman font size valign aduro biotech valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign janssen biotech style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom border bottom solid font size font family time roman stephen isaac valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style margin margin bottom border bottom solid font size font family time roman scott white style font family time roman font size valign stephen isaac valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign scott white style font family time roman font size valign chairman president valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign president oncology table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center aduro patent schedule style font size margin margin bottom nbsp style margin margin bottom logo style margin margin bottom font size font family time roman align center intellectual property relevant style margin margin bottom font size font family time roman align center intellectual property owned aduro style margin margin bottom font size font family time roman patent patent application owned aduro style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman integration vector license style margin margin bottom font size font family time roman style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align right nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style margin margin bottom font size font family time roman patent patent application style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align right nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center antigen schedule style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center antigen schedule style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center antigen schedule style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center antigen schedule style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center antigen schedule style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center antigen schedule style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center antigen schedule style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center submission manufacturing update plan schedule style margin margin bottom text indent font size font family time roman page omitted style margin margin bottom text indent font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center technology transfer plan schedule style margin margin bottom font size font family time roman page omitted style margin margin bottom font size font family time roman align center style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center subset schedule style margin margin bottom text indent font size font family time roman style margin margin bottom font size font family time roman align right style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center platform update schedule style margin margin bottom font size font family time roman this schedule defines information that will provided platform update from aduro same schedule agreement their listeria monocytogenes based technology platform style margin margin bottom font size font family time roman should following event happen prior year related listeria monocytogenes based technology platform summary event will included report style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center press release schedule style margin margin bottom logo style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman align center aduro expands collaboration with johnson nbsp johnson innovation style margin margin bottom font size font family time roman align center janssen lung cancer immunotherapy style margin margin bottom font size font family time roman berkeley calif business wire aduro biotech leader cancer immunotherapy today announced that entered into second agreement with janssen biotech part janssen pharmaceutical company johnson nbsp johnson granting exclusive worldwide license certain product candidate engineered treatment lung cancer certain other cancer based novel ladd immunotherapy platform under agreement facilitated johnson nbsp johnson innovation center california aduro will receive million front payment eligible receive significant development regulatory commercialization milestone payment potential total million addition aduro eligible receive high single digit double digit tiered royalty worldwide sale upon successful launch commercialization style margin margin bottom font size font family time roman under agreement janssen will have exclusive right develop commercialize ladd product candidate lung cancer will assume responsibility research development manufacturing regulatory commercialization activity licensed product aduro provide assistance these area upon request will receive additional these support activity style margin margin bottom font size font family time roman since initial agreement with janssen this year immunotherapy prostate cancer they have been terrific partner established strong collaboration focused advancing technology forward their licensed indication said stephen isaac chairman president chief executive officer aduro believe ladd technology also offer tremendous promise potential treatment lung cancer pleased expand relationship with janssen company with significant experience resource focused both lung prostate cancer separately aduro continues make progress with broad array immunotherapy platform number other oncology indication including pancreatic cancer mesothelioma glioblastoma among others style margin margin bottom font size font family time roman transaction subject clearance antitrust authority under hart scott rodino will become final soon such clearance occurred style margin margin bottom font size font family time roman this year aduro announced first agreement with janssen biotech granting company exclusive worldwide license certain product candidate specifically engineered treatment prostate cancer based novel ladd immunotherapy platform under that agreement also facilitated johnson nbsp johnson innovation center california aduro eligible receive million upfront development commercialization milestone style margin margin bottom font size font family time roman about ladd style margin margin bottom font size font family time roman ladd aduro proprietary platform live attenuated double deleted listeria monocytogenes strain that have been engineered induce potent innate immune response express tumor associated antigen induce tumor specific cell mediated immunity style margin margin bottom font size font family time roman about aduro biotech style margin margin bottom font size font family time roman aduro biotech private clinical stage biotechnology company focused immunotherapy cancer aduro received breakthrough therapy designation from novel immunotherapy combination pancreatic cancer which ongoing phase clinical trial eclipse additional ongoing clinical trial with ladd platform mesothelioma glioblastoma company also developing clinical candidate using novel small molecule that activate intracellular sting receptor central mediator innate immune response more information please visit aduro style margin margin bottom font size font family time roman contact style margin margin bottom font size font family time roman aduro biotech style margin margin bottom font size font family time roman greg schafer style margin margin bottom font size font family time roman chief operating officer style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman medium contact style margin margin bottom font size font family time roman angela bitting style margin margin bottom font size font family time roman bitting comcast style margin margin bottom font size font family time roman source aduro biotech style font size margin margin bottom nbsp style margin margin bottom logo style margin margin bottom font size font family time roman view this news release online style margin margin bottom font size font family time roman http businesswire news home style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center third party patent schedule style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center calendar year schedule style margin margin bottom font size font family time roman align center universal financial calendar style font size margin margin bottom nbsp style margin margin bottom align center logo style font size margin margin bottom nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center invoicing procedure schedule style margin margin bottom font size font family time roman align center invoicing process development work other development technology transfer plan payment style margin margin bottom font size font family time roman cost payment invoiced aduro pursuant development work other development technology transfer plan shall payable aduro within sixty calendar from date invoice respect same received shall cause paid aduro wire transfer electronic fund transfer credit bank account designated writing aduro style margin margin bottom font size font family time roman such invoice must reference valid purchase order number which shall provide aduro within calendar after execution date invoice shall include nature amount service rendered deliverable provided other basis payment aduro shall provide proper support expense included invoice reasonable support document pocket expense include invoice forma invoice from third party vendor reimbursement proper support includes time report break down function style margin margin bottom font size font family time roman invoice must sent johnson nbsp johnson account payable department aduro establishes invoice account sent postal mail following address style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman aduro contact johnson nbsp johnson account payable hotline united state with question related status payment invoice copy invoice shall sent concurrently finance director johnson nbsp johnson innovation reserve right return aduro unprocessed unpaid those invoice that reference applicable number janssen research nbsp development paying agent under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended style margin margin bottom font size nbsp body html text document